2009, Labelling and Pharmaceutical Companies

From data to impact: How real-world evidence will transform healthcare

pharmaphorum

JULY 7, 2025

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Insurance Coverage and Processing

Insurance Coverage and Processing Diabetes Pharmaceutical Companies Pharmaceutical Companies

Why security-first design is the fix to stalling AI pilot tools

pharmaphorum

JULY 2, 2025

Skip to main content Wednesday 2 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Development

J&J bids to extend prostate cancer uses for Akeega

pharmaphorum

JULY 7, 2025

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Labelling

Moderna shines spotlight on new flu vaccine data

pharmaphorum

JUNE 30, 2025

Skip to main content Monday 30 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Vaccines

Vaccines Diabetes Pharmaceutical Companies Pharmaceutical Companies

FDA OPDP Look Back at 2021 – The Yawning Gap

Eye on FDA

JANUARY 9, 2022

As noted in the past, there are two primary means for understanding the agency’s latest thinking with respect to promotional communications from pharmaceutical companies – the content and pattern of enforcement and the issuance of guidance documents to shed light on the parameters that exist. in November 2009.

Communication

Communication Documentation Labelling Pharmaceutical Companies

Case Study 5 – Regulatory Affairs Strategy and Project Team Lead

Syner-G

AUGUST 9, 2022

IMPACT (now part of Syner-G BioPharma Group) has been providing Regulatory Affairs support to a mid-size pharmaceutical company since 2009. Even though this company has a Regulatory Affairs Department, their rapid growth over the years has made “in-sourcing” of help a necessity.

Labelling

Labelling Pharmaceutical Companies Pharmaceutical Companies

Tracking the Drug Trail

Pharmaceutical Technology

MAY 11, 2008

Pharmaceutical companies, regulatory agencies and governments are becoming increasingly concerned about fraud and counterfeiting throughout the pharmaceutical supply chain, especially with the cost of drugs going up.

Packaging

Packaging Labelling Pharmaceutical Companies Pharmaceutical Companies

Time for FDA’s OPDP to Fill the Gaps on Digital and Social Media

Eye on FDA

JULY 7, 2020

The drug in question is Schedule II drug and bears a Boxed Warning on its label, yet the link contained no risk information about the drug, despite the fact that there was present information about the benefits of the drug, according to OPDP’s letter. This item disappeared from the agenda, however, and no draft guidance was issued.

Communication

Communication Documentation Labelling Pharmaceutical Companies

Japan’s M&A Boom

Pharmaceutical Technology

OCTOBER 5, 2008

“The business integration from 2005 to 2007 of the two separate companies to form the joint Daiichi Sankyo created one of Japan’s biggest pharmaceutical companies.” Like in many other sectors, China and India are the ones labelled as those which will lead the expansion.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Labelling Diabetes

Top 20 Radiopharma Companies Based on Market Cap

PharmaShots

FEBRUARY 21, 2023

The company expects to commence P-I clinical trials on metastatic and pediatric primary bone cancer patients. FAP-2286 (labeled with lutetium-177), a peptide-targeted radionuclide therapy (PTRT) and imaging agent targeting fibroblast activation protein (FAP), is the company’s lead asset amongst radiopharma products.

Dosage

Dosage Labelling Pharmaceutical Companies Immunization

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2003-2022)

PharmaShots

APRIL 13, 2023

model is a holistic approach to incorporate the same strategy to life science and pharmaceutical companies. A globally fast-growing, and largest pharmaceutical company in the world was created through a merger between Pfizer and Pharmacia. Model: Inspired by the industry 4.0 model, the pharma 4.0

Pharmacist Digest

From data to impact: How real-world evidence will transform healthcare

Why security-first design is the fix to stalling AI pilot tools

Trending Sources

J&J bids to extend prostate cancer uses for Akeega

Moderna shines spotlight on new flu vaccine data

FDA OPDP Look Back at 2021 – The Yawning Gap

Case Study 5 – Regulatory Affairs Strategy and Project Team Lead

Tracking the Drug Trail

Time for FDA’s OPDP to Fill the Gaps on Digital and Social Media

Japan’s M&A Boom

Top 20 Radiopharma Companies Based on Market Cap

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2003-2022)

Stay Connected